Michael Havens, MD
Family Medicine · Batesville, MSNPI 1316928955
Payments from drug & device makers
Across 186 payments — averaging $18.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$707
- Novo Nordisk$563
- AstraZeneca$479
- Bayer$358
- Teva Pharmaceuticals USA, Inc.$186
- Lilly USA, LLC$171
- plus $992 from 29 others
What the payments were for
- Food & beverage$3,454100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 49 | $707 |
| Novo Nordisk | 31 | $563 |
| AstraZeneca | 18 | $479 |
| Bayer | 20 | $358 |
| Teva Pharmaceuticals USA, Inc. | 10 | $186 |
| Lilly USA, LLC | 8 | $171 |
| Amgen | 6 | $118 |
| Inspire Medical Systems, Inc. | 2 | $91 |
| Boston Scientific | 3 | $82 |
| Phathom Pharmaceuticals, Inc. | 5 | $77 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $55 |
| Abbott | 2 | $43 |
| Pfizer | 2 | $39 |
| Shield Therapeutics Inc | 2 | $36 |
| GSK | 2 | $36 |
| Genentech USA, Inc. | 2 | $36 |
| Electromed, Inc. | 3 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Johnson & Johnson | 1 | $27 |
| Galderma Laboratories, L.p. | 1 | $23 |
| Dexcom, Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Baxter Healthcare | 1 | $21 |
| Ironwood Pharmaceuticals, Inc | 1 | $20 |
| Mylan Specialty L.p. | 1 | $19 |
| Ardelyx, Inc. | 1 | $17 |
| Merck | 1 | $17 |
| Medtronic | 1 | $16 |
| Novartis | 1 | $16 |
| Boehringer Ingelheim | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
How this compares
$3,454 in reported general payments places this provider in the 80th percentile of 971 family medicine providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $587 |
| Omeprazole | 44 | $394 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $392 |
| Gabapentin | 16 | $291 |
| Alprazolam | 37 | $285 |
| Levothyroxine Sodium | 14 | $156 |
| Metformin Hcl ErMetformin Hcl | 11 | $150 |
| Amlodipine Besylate | 45 | $136 |
| Tamsulosin Hcl | 16 | $104 |
| Atorvastatin Calcium | 20 | $102 |
| Lorazepam | 12 | $91 |
| Carvedilol | 22 | $90 |
| Furosemide | 15 | $82 |
| Ezetimibe | 11 | $77 |
| Losartan Potassium | 18 | $61 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Batesville
- Paul MatherneGulfport$14.4M
- Timothy QuinnRidgeland$8M
- Sean KerbyGulfport$6.6M
- Rambod RouhbakhshHattiesburg$6M
- Randall HulingOlive Branch$4.6M
- Demetri MarshallPort Gibson$3M
- Alexander OsowaJackson$2.2M
- Russell CarlisleWesson$1.6M
- Kristi TrimmRidgeland$1.2M
- Keith StokesLexington$660K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.